Back
Denali Therapeutics Stock Price Chart
Sponsored
DNLI
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.74
Seasonality Move:
17.79%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
Denali Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28 | Buy |
20-day SMA: | 26.04 | Buy |
50-day SMA: | 24.18 | Buy |
200-day SMA: | 20.53 | Buy |
8-day EMA: | 28.54 | Buy |
20-day EMA: | 26.57 | Buy |
50-day EMA: | 24.56 | Buy |
200-day EMA: | 22.12 | Buy |
Denali Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.67 | Buy |
Relative Strength Index (14 RSI): | 77.92 | Buy |
Chaikin Money Flow: | 34344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.24 - 27.72) | Buy |
Bollinger Bands (100): | (18.96 - 25.08) | Buy |
Denali Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 30.68 while DNLI 8-day simple moving average is 28.00, which is a Buy signal.
- The stock price of DNLI is 30.68 while Denali Therapeutics 20-day SMA is 26.04, which makes it a Buy.
- Denali Therapeutics 50-day simple moving average is 24.18 while DNLI share price is 30.68, making it a Buy technically.
- DNLI stock price is 30.68 and Denali Therapeutics 200-day simple moving average is 20.53, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Buy
The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Denali Therapeutics Stock Info
Market Cap:
4.39B
Price in USD:
30.68
Share Volume:
1.33M
Denali Therapeutics 52-Week Range
52-Week High:
31.15
52-Week Low:
14.56
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 30.68 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is not overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 30.68 while DNLI 8-day exponential moving average is 28.54, which is a Buy signal.
- The stock price of DNLI is 30.68 while Denali Therapeutics 20-day EMA is 26.57, which makes it a Buy.
- Denali Therapeutics 50-day exponential moving average is 24.56 while DNLI share price is 30.68, making it a Buy technically.
- DNLI stock price is 30.68 and Denali Therapeutics 200-day simple moving average is 22.12, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is 1.67, suggesting Denali Therapeutics is a Buy
- Denali Therapeutics Relative Strength Index (RSI) is 77.92, which suggest Denali Therapeutics is overbought
- The Bollinger Bands (25) for Denali Therapeutics is (23.24 - 27.72), which suggest Denali Therapeutics is a Buy
- The Bollinger Bands (100) for Denali Therapeutics is (18.96 - 25.08), which suggest Denali Therapeutics is a Buy
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.